3,4-dihydroxyphenylacetic acid has been researched along with 6-hydroxydopa in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berta, B; Gálosi, R; Kállai, V; Kovács, A; Lénárd, L; Ollmann, T; Péczely, L; Petykó, Z; Tóth, A | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 6-hydroxydopa
Article | Year |
---|---|
Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-2 Receptor Antagonists; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Male; Neural Pathways; Neurons; Norepinephrine; Oxidopamine; Piperazines; Prefrontal Cortex; Rats, Wistar; Yohimbine | 2018 |